4//SEC Filing
Theagene Jean-Manasse 4
Accession 0001127602-24-000643
CIK 0001878313other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 8:57 PM ET
Size
5.2 KB
Accession
0001127602-24-000643
Insider Transaction Report
Form 4
Theagene Jean-Manasse
Director
Transactions
- Award
Stock Options
2023-12-31+15,418→ 15,418 totalExercise: $1.17From: 2023-12-31Exp: 2033-12-31→ Common Stock (15,418 underlying)
Footnotes (1)
- [F1]The stock options, granted on December 31, 2023 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date.
Documents
Issuer
MAIA Biotechnology, Inc.
CIK 0001878313
Entity typeother
Related Parties
1- filerCIK 0001969857
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 8:57 PM ET
- Size
- 5.2 KB